
1. Technology overview
Sleepiz AG is a medtech company headquartered at Hornbachstrasse 23, 8008 Zurich, founded in Zurich in 2018. The site lists a team of more than 35 and affiliates in the USA, Germany and India. It develops contactless vital-sign monitoring for care facilities and clinical trials.
Sleepiz One+ is a wall-mounted radar device that measures bed presence, respiration rate and heart rate and sends bed-exit notifications. Data appear on a web dashboard with longitudinal trends and a multi-resident view. The device runs on standard Wi-Fi, takes about five minutes to set up per room, and encrypts data in transit and at rest. The company targets nursing homes, assisted living and senior care, and offers a separate pharma clinical-trial program.
2. Highlighted features & specifications
- Bed presence: Detects presence and body movement in bed.
- Vital signs: Measures respiration rate and heart rate by radar.
- Bed-exit alerts: Sends notifications when a resident leaves the bed.
- Dashboard: Web dashboard with longitudinal trends and a multi-resident view.
- Simple installation: Wall-mounted unit on standard Wi-Fi, set up in about five minutes per room.
- Data security: Encryption in transit and at rest.
3. Potential application
Nursing homes and senior-care centers in Vietnam monitoring night-time breathing and bed exits. Hospital wards for non-critical vital-sign trends. Clinical research sites needing contactless endpoints.
4. Benefits
Contactless measurement without wearables or cables on residents. Quick setup of about five minutes per room on standard Wi-Fi. Trend data on a dashboard helps staff review multiple residents. CE Class IIa and FDA 510(k) status support procurement in regulated markets.
5. Market trends & opportunities
Population ageing is raising demand for remote and unobtrusive monitoring in elderly care. Vietnam and other Southeast Asian markets are expanding senior-care facilities, where contactless sensing reduces the burden on nursing staff.
6. Other information
Founded in Zurich in 2018; affiliates Sleepiz USA LLC (Irvine), Sleepiz Germany GmbH (Berlin) and Sleepiz (India) Pvt. Ltd (Pune). CE mark Class IIa (2020, TUV SUD) and FDA 510(k) K253388 decided 28 January 2026 per the FDA database. Won EIT Health European Health Catapult in 2019. The device is a prescription device and is not indicated for emergency alarms.
One platform connecting startups, corporations, research institutions, regions and investors











Playbook & Handbook · February 6, 2026
Winning Accelerator Playbook 2026 by BambuUP
RETAIL E-COMMERCE: AI AND REAL-TIME DATA ARE TRANSFORMING HOW RETAIL BUSINESSES OPERATE








































